Sam Brusco, Associate Editor03.27.24
GE HealthCare has launched its Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature to support ultrasound-guided prostate imaging, biopsies, and treatment guidance.
The company said the PVA software can determine organ calculations and measurements with an automated, one-click process.
Measuring prostate volume can be helpful to identify and plan treatment for several prostate diseases, including prostate cancer where the calculations are critical to determine prostate-specific antigen density (PSAD). The disease burden continues to grow, creating the need for effective prevention, management, and treatment strategies.
PVA will be available on the bkActiv, bk3000/5000, and bkSpecto active imaging systems. The next-gen bkActiv uses advanced algorithms to automatically optimize image clarity for high-detail image quality. bkSpecto and bk3000/5000 offer high-quality ultrasound guidance for urology procedures, as well.
The company will debut the new AI software at the European Association of Urology Congress in Paris on April 5-8 and American Urological Association Annual Meeting in San Antonio on May 3-6.
“Normally, clinicians determine prostate volume through a manual, repetitive process that requires measuring multiple dimensions and applying a mathematical formula,” said Fredrik Gran, Head of Innovation, Surgical Visualization and Guidance, Ultrasound at GE HealthCare. “Prostate Volume Assist uses artificial intelligence to automate this process with a single click, and yield results in less than two seconds. This technology provides an added level of support for urologists to improve efficiencies in the workflow and enable precision care.”
"As a trusted partner for urologists around the world, we are proud to offer Prostate Volume Assist technology to expand the capabilities of our active imaging systems,” added Urvi Vyas, General Manager, Surgical Visualization and Guidance, Ultrasound at GE HealthCare. “This technology provides urologists with a unique solution to enhance workflows, guide surgical urology procedures, and allow them to quickly retrieve the important details they need to make critical treatment decisions.”
The company said the PVA software can determine organ calculations and measurements with an automated, one-click process.
Measuring prostate volume can be helpful to identify and plan treatment for several prostate diseases, including prostate cancer where the calculations are critical to determine prostate-specific antigen density (PSAD). The disease burden continues to grow, creating the need for effective prevention, management, and treatment strategies.
PVA will be available on the bkActiv, bk3000/5000, and bkSpecto active imaging systems. The next-gen bkActiv uses advanced algorithms to automatically optimize image clarity for high-detail image quality. bkSpecto and bk3000/5000 offer high-quality ultrasound guidance for urology procedures, as well.
The company will debut the new AI software at the European Association of Urology Congress in Paris on April 5-8 and American Urological Association Annual Meeting in San Antonio on May 3-6.
“Normally, clinicians determine prostate volume through a manual, repetitive process that requires measuring multiple dimensions and applying a mathematical formula,” said Fredrik Gran, Head of Innovation, Surgical Visualization and Guidance, Ultrasound at GE HealthCare. “Prostate Volume Assist uses artificial intelligence to automate this process with a single click, and yield results in less than two seconds. This technology provides an added level of support for urologists to improve efficiencies in the workflow and enable precision care.”
"As a trusted partner for urologists around the world, we are proud to offer Prostate Volume Assist technology to expand the capabilities of our active imaging systems,” added Urvi Vyas, General Manager, Surgical Visualization and Guidance, Ultrasound at GE HealthCare. “This technology provides urologists with a unique solution to enhance workflows, guide surgical urology procedures, and allow them to quickly retrieve the important details they need to make critical treatment decisions.”